Condition
Erythrocytosis
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed3
Terminated1
Not Yet Recruiting1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06785870Not Yet RecruitingPrimary
EVAluation of Erythrocytosis PRospEctive Cohort STudy
NCT04751292Completed
HIGH Altitude CArdiovascular REsearch Latin America Population Study
NCT05833477Not ApplicableCompletedPrimary
Tracing Changed Production of Red Blood Cells
NCT05118048Terminated
StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood
NCT02548117Phase 3WithdrawnPrimary
H-36731: Finasteride in Management of Elevated Red Blood Cells
NCT01187108Phase 1CompletedPrimary
Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru
Showing all 6 trials